Skip to content
PubMed This is a summary of 11 peer-reviewed journal articles Updated
Clinical Genetics

Genetics and the KIDINS220 Gene

At a Glance

Macrocephaly-spastic paraplegia-dysmorphism syndrome is linked to KIDINS220 variants. One affected copy often causes the SINO pattern, while changes in both copies may cause the more severe VENARG pattern; parental testing clarifies inheritance and future pregnancy risk.

To understand your child’s diagnosis, it helps to think of the KIDINS220 gene as a master architect for the developing brain. This gene provides the instructions for a protein called ARMS (Ankyrin Repeat-Rich Membrane Spanning), which acts like a “scaffold” or a central hub in nerve cells [1]. It organizes the signals that tell neurons how to grow, survive, and connect with one another [2][3].

When a “glitch” or mutation occurs in this gene, the scaffold is built incorrectly. This disrupts the way signals travel through the nervous system, leading to the challenges with movement, learning, and vision seen in KIDINS220-related disorders [4][5].

Two Ways the Gene Can Be Affected

Not all changes to the KIDINS220 gene are the same. Scientists have identified two main ways these mutations are inherited, which often lead to different sets of symptoms, though zygosity alone does not perfectly predict the phenotype [6].

  • Autosomal Dominant (The SINO Pattern): This happens when only one of the two copies of the KIDINS220 gene is mutated. This is the most common pattern for SINO syndrome [4]. In many cases, these mutations are de novo, meaning they occurred spontaneously in the child and were not passed down by the parents [7]. In this pattern, the “glitch” often happens at the very end of the gene (the C-terminal), creating a shortened, or “truncated,” protein that gets in the way of the healthy protein [5][8].
  • Autosomal Recessive (The VENARG Pattern): This is much rarer and occurs when both copies of the gene are mutated—usually because the child inherited one mutated copy from each parent [6][9]. This “double glitch” often causes the body to stop making the KIDINS220 protein entirely. Because the protein is so vital, this pattern usually leads to more severe symptoms, such as VENARG, which can involve significant brain fluid enlargement (ventriculomegaly) and joint stiffness (contractures) that are often visible even before birth [6][9].

Decoding Your Genetic Report

A genetic report can feel like it’s written in a different language. Here are the key “coordinates” you should look for to understand your child’s specific situation:

Term What it Means Why it Matters
Gene KIDINS220 Confirms this is the specific “instruction manual” affected.
Variant The specific “typo” (e.g., c.4144G>T) Tells doctors exactly where the error is located in the gene [7].
Zygosity Heterozygous or Biallelic Heterozygous means one copy is affected (usually SINO); Biallelic means two copies are affected (usually VENARG) [6].
Protein Change e.g., p.Glu1382* Describes how the protein was built differently (the “*” often means the protein was cut short) [7].
Inheritance De novo or Inherited De novo means it started with the child; Inherited means it was passed from a parent [4].

Caution: A Variant of Uncertain Significance (VUS) should not be used by itself for reproductive or treatment decisions. Classification requires a specialist’s interpretation.

Why Rarity Makes a Difference

Because the KIDINS220 gene is so large and its role is so complex, different mutations can cause slightly different symptoms. For example, some children might have more eye issues (nystagmus), while others have more difficulty with muscle stiffness [5].

You may also see the term NMD (Nonsense-Mediated Decay) on a report. This is a “quality control” process in our cells that destroys broken genetic instructions. In many SINO cases, the mutation “escapes” this cleanup, allowing a truncated protein to be made, which then interferes with brain development [8][6]. This mechanism, however, is variant-specific and does not apply to all mutations [5].

Family Planning and Inheritance

If your child’s mutation is de novo, the risk of having another child with the condition is generally very low—often estimated at around 1% due to possible parental germline mosaicism [10]. However, if a parent carries the autosomal-dominant mutation, the risk is 50% for each future pregnancy [8]. If both parents are carriers of a recessive condition, there is a 25% risk of an affected pregnancy, a 50% chance of a carrier, and a 25% chance of an unaffected child. Parental testing and a consultation with a genetic counselor are highly recommended [11][6].

Common questions in this guide

What does the KIDINS220 gene do?
KIDINS220 provides instructions for ARMS, a protein that helps organize signals in nerve cells. Changes in the gene can disrupt how neurons grow, survive, and connect, contributing to movement, learning, and vision problems.
What is the difference between one and two KIDINS220 variants?
A heterozygous result means one copy is affected and is commonly associated with the SINO pattern. A biallelic result means both copies are affected and is often associated with the more severe VENARG pattern. Zygosity alone does not predict every symptom.
What does a de novo KIDINS220 variant mean for another pregnancy?
De novo means the variant arose in the child rather than being inherited from either parent. The chance of another affected pregnancy is generally low, often estimated around 1% because a parent may have a small amount of the variant in reproductive cells. If a parent carries an autosomal-dominant variant, the chance is 50% in each pregnancy.
Why is parental testing important for a KIDINS220 result?
Testing both parents can show whether a child’s variant is new or inherited and can clarify whether one or both gene copies are affected. These results help a genetic counselor estimate recurrence risk and discuss reproductive options.
What does VUS mean on a KIDINS220 genetic report?
A variant of uncertain significance, or VUS, is a gene change whose effect is not yet clear. A VUS should not be used by itself to make treatment or reproductive decisions; a genetics specialist must interpret it with the child’s clinical findings and other evidence.
What do C-terminal and nonsense-mediated decay mean in a KIDINS220 report?
The C-terminal is the end region of the KIDINS220 protein, where some SINO-associated changes occur. Nonsense-mediated decay is a cellular quality-control process that can destroy faulty genetic instructions, but whether a variant escapes it depends on the specific variant.
What are the pregnancy risks if both parents carry a recessive KIDINS220 variant?
For two carrier parents, each pregnancy has a 25% chance of being affected, a 50% chance of being a carrier, and a 25% chance of being unaffected. A genetic counselor can explain how these probabilities apply to your family’s specific variants.

Get notified when new evidence is published on Macrocephaly-spastic paraplegia-dysmorphism syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (11)
  1. 1

    Stepping Out of the Shade: Control of Neuronal Activity by the Scaffold Protein Kidins220/ARMS.

    Scholz-Starke J, Cesca F

    Frontiers in cellular neuroscience 2016; (10()):68 doi:10.3389/fncel.2016.00068.

    PMID: 27013979
  2. 2

    Development of a neuroprotective peptide that preserves survival pathways by preventing Kidins220/ARMS calpain processing induced by excitotoxicity.

    Gamir-Morralla A, López-Menéndez C, Ayuso-Dolado S, et al.

    Cell death & disease 2015; (6()):e1939 doi:10.1038/cddis.2015.307.

    PMID: 26492372
  3. 3

    Kidins220 sets the threshold for survival of neural stem cells and progenitors to sustain adult neurogenesis.

    Del Puerto A, Lopez-Fonseca C, Simón-García A, et al.

    Cell death & disease 2023; (14(8)):500 doi:10.1038/s41419-023-05995-7.

    PMID: 37542079
  4. 4

    Heterozygous KIDINS220/ARMS nonsense variants cause spastic paraplegia, intellectual disability, nystagmus, and obesity.

    Josifova DJ, Monroe GR, Tessadori F, et al.

    Human molecular genetics 2016; (25(11)):2158-2167 doi:10.1093/hmg/ddw082.

    PMID: 27005418
  5. 5

    Refining the phenotype of SINO syndrome: A comprehensive cohort report of 14 novel cases.

    Alstrup M, Cesca F, Krawczun-Rygmaczewska A, et al.

    Genetics in medicine : official journal of the American College of Medical Genetics 2024; (26(11)):101219 doi:10.1016/j.gim.2024.101219.

    PMID: 39033379
  6. 6

    Novel autosomal recessive SINO syndrome-associated KIDINS220 variants provide insight into the genotype-phenotype correlation.

    Yang W, Wang S, Huo X, et al.

    Heliyon 2024; (10(17)):e37355 doi:10.1016/j.heliyon.2024.e37355.

    PMID: 39296002
  7. 7

    A Novel KIDINS220 Pathogenic Variant Associated with the Syndromic Spastic Paraplegia SINO: An Expansion of the Brain Malformation Spectrum and a Literature Review.

    Bonati MT, Baldoli C, Taurino J, et al.

    Genes 2024; (15(9)) doi:10.3390/genes15091190.

    PMID: 39336781
  8. 8

    Gain-of-Function KIDINS220 Variants Disrupt Neuronal Development and Cause Cerebral Palsy.

    Zhang J, Zhang Y, Shang Q, et al.

    Movement disorders : official journal of the Movement Disorder Society 2024; (39(3)):498-509 doi:10.1002/mds.29694.

    PMID: 38148610
  9. 9

    Homozygous KIDINS220 loss-of-function variants in fetuses with cerebral ventriculomegaly and limb contractures.

    Mero IL, Mørk HH, Sheng Y, et al.

    Human molecular genetics 2017; (26(19)):3792-3796 doi:10.1093/hmg/ddx263.

    PMID: 28934391
  10. 10

    Parental mosaicism in epilepsies due to alleged de novo variants.

    Møller RS, Liebmann N, Larsen LHG, et al.

    Epilepsia 2019; (60(6)):e63-e66 doi:10.1111/epi.15187.

    PMID: 31077350
  11. 11

    Prenatal Diagnosis of a KIDINS220 De Novo Heterozygous Variant in a Fetus With a Complex CNS Anomaly.

    Miremberg H, Birnbaum R, Trigubov D, et al.

    Prenatal diagnosis 2024; (44(12)):1518-1521 doi:10.1002/pd.6682.

    PMID: 39367534

This page is for informational purposes only and does not constitute medical advice. A clinical geneticist or genetic counselor should interpret your child’s KIDINS220 report and discuss family-planning options.